This week, executive chairman of Izon Science, Hans van der Voorn, presented a professor at the Indian Institute of Technology-Bombay with a device that could change the way nanoparticles are delivered to their target. The tool could help deliver cancer drugs, like chemotherapy, directly to tumors, without damaging the rest of your body. This could also mean less side effects, producing a better quality of life.
Izon Science’s Hans van der Voorn says, “We’re very pleased to be contributing to Prof. Banerjee’s very important research work into controlled release drug delivery. This research could lead to the development of high value added products that could really make a difference to people’s wellbeing worldwide, as well as to the Indian economy. This device doesn’t just mean a breakthrough in drug delivery, but also sets the precedent for how companies are working together to build better relationships.
India and New Zealand aren’t the only ones who are combining innovation and research skills from across the globe. Check out our exclusive interview with Michael Kaufman, Vice President, Pharmaceutical Sciences, Millennium Pharmaceuticals, as he discusses the future of partnering strategy here.
Want to learn more about about how devices and combination products are changing the drug delivery game?At DDP, hundreds of pharmaceutical and drug delivery thought leaders come together to develop partnerships to create the next great product that will bring relief to millions of patients. Download our brochure for the 17th Annual Drug Delivery Partnerships Conference taking place this February 6-8, 2012, in San Diego, CA.
As a reader of this blog, you get a 15% discount off the standard rate when you register to join us when
using code XP1878BLOG.